1. Home
  2. CLWT vs BIVI Comparison

CLWT vs BIVI Comparison

Compare CLWT & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CLWT

Euro Tech Holdings Company Limited

HOLD

Current Price

$1.45

Market Cap

11.3M

ML Signal

HOLD

Logo BioVie Inc.

BIVI

BioVie Inc.

BUY

Current Price

$1.13

Market Cap

12.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
CLWT
BIVI
Founded
1971
2013
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Professional and commerical equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3M
12.7M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
CLWT
BIVI
Price
$1.45
$1.13
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $5.26
AVG Volume (30 Days)
★ 1.4M
227.2K
Earning Date
04-30-2026
11-09-2026
Dividend Yield
★ 9.39%
N/A
EPS Growth
N/A
★ 74.83
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.56
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$0.82
52 Week High
$2.68
$3.79

Technical Indicators

Market Signals
Indicator
CLWT
BIVI
Relative Strength Index (RSI) 51.02 29.54
Support Level $1.46 $1.15
Resistance Level $1.74 $1.32
Average True Range (ATR) 0.15 0.09
MACD 0.03 -0.03
Stochastic Oscillator 23.85 4.17

Price Performance

Historical Comparison
CLWT
BIVI

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is mainly a distributor of a wide range of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies, and power generation equipment, including recorders and power quality analyzers. The Company acts as an exclusive or non-exclusive distributor for manufacturers of such equipment to commercial customers and governmental agencies in Hong Kong and mainland China, as well as commercial customers in Macau. It has two operating segments: Trading and manufacturing, which generate maximum revenue and act as a distributor of water treatment equipment, laboratory instruments, analyzers, test kits, related supplies, and power generation equipment; and the Engineering segment. The Company generates maximum revenue from the PRC.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies for the treatment of neurological and neurodegenerative disorders and liver disease. Its therapeutic areas include Alzheimer's, Parkinson's, Long COVID, Ascites, Longevity, and Epigenetics. In liver disease, its investigational drug candidate BIV201 (continuous infusion terlipressin) was granted FDA Fast Track status and FDA Orphan Drug designation for ascites due to all etiologies except cancer. BIV201 is being evaluated as a treatment option for patients suffering from life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism.

Share on Social Networks: